BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Calbo E, Alsina M, Rodríguez-Carballeira M, Lite J, Garau J. Systemic expression of cytokine production in patients with severe pneumococcal pneumonia: effects of treatment with a beta-lactam versus a fluoroquinolone. Antimicrob Agents Chemother 2008;52:2395-402. [PMID: 18426893 DOI: 10.1128/AAC.00658-07] [Cited by in Crossref: 27] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Altan F, Sayin Ipek DN, Corum O, Yesilmen Alp S, Ipek P, Uney K. The effects of Mannheimia haemolytica and albendazole on marbofloxacin pharmacokinetics in lambs. Trop Anim Health Prod 2019;51:2603-10. [PMID: 31230255 DOI: 10.1007/s11250-019-01980-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Anderson R, Tintinger G, Cockeran R, Potjo M, Feldman C. Beneficial and Harmful Interactions of Antibiotics with Microbial Pathogens and the Host Innate Immune System. Pharmaceuticals (Basel) 2010;3:1694-710. [PMID: 27713324 DOI: 10.3390/ph3051694] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
3 Havers F, Bramley AM, Finelli L, Reed C, Self WH, Trabue C, Fakhran S, Balk R, Courtney DM, Girard TD, Anderson EJ, Grijalva CG, Edwards KM, Wunderink RG, Jain S. Statin Use and Hospital Length of Stay Among Adults Hospitalized With Community-acquired Pneumonia. Clin Infect Dis 2016;62:1471-8. [PMID: 27169476 DOI: 10.1093/cid/ciw174] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
4 Rincón-López EM, Navarro Gómez ML, Hernández-Sampelayo Matos T, Aguilera-Alonso D, Dueñas Moreno E, Saavedra-Lozano J, Santiago García B, Santos Sebastián MDM, García Morín M, Beléndez Bieler C, Lorente Romero J, Cela de Julián E; F-DREP Study Group. Interleukin 6 as a marker of severe bacterial infection in children with sickle cell disease and fever: a case-control study. BMC Infect Dis 2021;21:741. [PMID: 34344349 DOI: 10.1186/s12879-021-06470-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Zierath D, Kunze A, Fecteau L, Becker K. Effect of Antibiotic Class on Stroke Outcome. Stroke 2015;46:2287-92. [PMID: 26138122 DOI: 10.1161/STROKEAHA.115.008663] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
6 Herta T, Bhattacharyya A, Rosolowski M, Conrad C, Gurtner C, Gruber AD, Ahnert P, Gutbier B, Frey D, Suttorp N, Hippenstiel S, Zahlten J. Krueppel-Like Factor 4 Expression in Phagocytes Regulates Early Inflammatory Response and Disease Severity in Pneumococcal Pneumonia. Front Immunol 2021;12:726135. [PMID: 34589087 DOI: 10.3389/fimmu.2021.726135] [Reference Citation Analysis]
7 Meikle CKS, Creeden JF, McCullumsmith C, Worth RG. SSRIs: Applications in inflammatory lung disease and implications for COVID-19. Neuropsychopharmacol Rep 2021;41:325-35. [PMID: 34254465 DOI: 10.1002/npr2.12194] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Patel A, Sangle GV, Trivedi J, Shengule SA, Thorve D, Patil M, Deshmukh NJ, Choudhari B, Karade A, Gupta S, Bhagwat S, Patel M. Levonadifloxacin, a Novel Benzoquinolizine Fluoroquinolone, Modulates Lipopolysaccharide-Induced Inflammatory Responses in Human Whole-Blood Assay and Murine Acute Lung Injury Model. Antimicrob Agents Chemother 2020;64:e00084-20. [PMID: 32152077 DOI: 10.1128/AAC.00084-20] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Cillóniz C, Ceccato A, de la Calle C, Gabarrús A, Garcia-Vidal C, Almela M, Soriano A, Martinez JA, Marco F, Vila J, Torres A. Time to blood culture positivity as a predictor of clinical outcomes and severity in adults with bacteremic pneumococcal pneumonia. PLoS One 2017;12:e0182436. [PMID: 28787020 DOI: 10.1371/journal.pone.0182436] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
10 Almuntashiri S, Han Y, Zhu Y, Dutta S, Niazi S, Wang X, Siddiqui B, Zhang D. CC16 Regulates Inflammation, ROS Generation and Apoptosis in Bronchial Epithelial Cells during Klebsiella pneumoniae Infection. Int J Mol Sci 2021;22:11459. [PMID: 34768890 DOI: 10.3390/ijms222111459] [Reference Citation Analysis]
11 Padrones S, Garcia-Vidal C, Fernández-Serrano S, Fernández A, Masuet C, Carratalà J, Coromines M, Ardanuy C, Gudiol F, Manresa F, Dorca J. Impact of antibiotic therapy on systemic cytokine expression in pneumococcal pneumonia. Eur J Clin Microbiol Infect Dis 2010;29:1243-51. [PMID: 20567869 DOI: 10.1007/s10096-010-0993-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
12 Head BM, Mao R, Keynan Y, Rueda ZV. Inflammatory mediators and lung abnormalities in HIV: A systematic review. PLoS One 2019;14:e0226347. [PMID: 31830103 DOI: 10.1371/journal.pone.0226347] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
13 Thiem U, Heppner HJ, Pientka L. Elderly patients with community-acquired pneumonia: optimal treatment strategies. Drugs Aging 2011;28:519-37. [PMID: 21721597 DOI: 10.2165/11591980-000000000-00000] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]